News for Atlanta Limited (ATLANTA.BO)

U.S. stock futures fell on Thursday following Wednesday’s relief after a two-day fall. Futures of all four benchmark indices fell in premarket trading. President Donald Trump’s administration postponed implementation of auto tariffs by one month on Wednesday after the tariffs on Canada, Mexico, and China were implemented on Tuesday.

Senores Pharmaceuticals acquires 14 ANDAs from Dr Reddy's Laboratories, aiming to capitalize on US policy changes.

U.S. stock futures rose on Monday following Friday's advances. Futures of all fourth benchmark indices rose in premarket trading.

US. stock futures rose on Monday following Friday's advances. Futures of all fourth benchmark indices rose in premarket trading.

U.S. stock futures rose on Wednesday following two consecutive days of mixed close this week. All futures advanced in premarket trading.

U.S. stock futures rose on Monday, following Friday's selloff. Futures of all four benchmark indices were trading higher.

U.S. stock futures fell on Wednesday after a mixed close on Tuesday as Federal Reserve Chairman Jerome Powell Congress testimony.

U.S. stock futures rose on Monday following Friday's sharp fall as investors digest tariff updates and earnings reports.

Senores Pharmaceuticals' focus remains on broadening their US base beyond injectables and exploring product acquisitions to fuel future growth, said Swapnil Shah, managing director of Senores Pharmaceuticals, as the company made a remarkable debut on the Indian stock exchanges. The Ahmedabad-based pharmaceutical firm's shares listed at Rs 600 on the National Stock Exchange, a premium of 53.45% over its issue price of Rs 391, while opening at Rs 593.70 on the BSE, a 51.84% jump.

Shares of Senores Pharmaceuticals Ltd. ended 6.33% lower than the listing price, at Rs 562 on the National Stock Exchange. The stock closed 5.39% down on the BSE, at Rs 561.70 per share. The company's shares had debuted on the National Stock Exchange at Rs 600 apiece, at a premium of 53.45% over issue price of Rs 391. The stock listed on the BSE at Rs 593.70 per share, marking a premium of 51.84%. Intraday, the stock rose as much as 55.9%, reaching Rs 609.65 per share.

Shares of Senores Pharmaceuticals Ltd. debuted on the National Stock Exchange at Rs 600 apiece, at a premium of 53.45% over issue price of Rs 391. The stock listed on the BSE at Rs 593.70 per share, marking a premium of 51.84%. Senores Pharmaceuticals' IPO, which closed on Dec. 24, was subscribed 93.41 times, with demand led by non-institutional investors. The Rs 582.1-crore offering consists of a fresh issue of Rs 500 crore and an offer for sale of Rs 82.1 crore.

Manufacturing unicorn Zetwerk has raised USD 90 million, about Rs 766 crore, in a fresh funding round at a valuation of USD 3.1 billion, a top company official said on Thursday. The valuation of the company was USD 2.7 billion early this year.

Stadiums are redefining premium seating by offering a larger range of spaces and amenities—including private cabanas under the stands, a visit from a mascot, even the chance to fly on the team plane. Here’s why courtside fans are now looking up in envy.

The surge in Atlantaa share price came after the company announced that it has received Commencement Certificate for its project, Atlanta Enclave Phase 11, from Thane Municipal Corporation: Atlantaa Shares

Share market today, August 29, 2024: Indian equities are expected to open lower; US GDP, Reliance Industries (RIL) 2024 AGM, Premiere Energies IPO on radar

Both indices ended the week with gains after posting declines in the previous two weeks

Senores Pharmaceuticals Ltd has filed preliminary papers with capital markets regulator Sebi to raise funds through an initial public offering (IPO).

The Nifty Auto index was trading 0.01 per cent down at 21982.0.

ZeroHedge - On a long enough timeline, the survival rate for everyone drops to zero